Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia

There is conflicting information about the influence of body mass index (BMI) on the pharmacokinetics, toxicity, and outcome of chemotherapy. We compared pharmacokinetics, outcome, and toxicity data across 4 BMI groups (underweight, BMI ≤ 10th percentile; normal; at risk of overweight, BMI ≥ 85th an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hijiya, Nobuko, Panetta, John C., Zhou, Yinmei, Kyzer, Emily P., Howard, Scott C., Jeha, Sima, Razzouk, Bassem I., Ribeiro, Raul C., Rubnitz, Jeffrey E., Hudson, Melissa M., Sandlund, John T., Pui, Ching-Hon, Relling, Mary V.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society of Hematology 2006
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895448/
https://ncbi.nlm.nih.gov/pubmed/16917005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-05-024414
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller